Emphysema

Clinical Effect of Emphysema in Individuals With HIV

The clinical significance of emphysema was greater in people living with HIV vs those without HIV.

Severe Emphysema Benefits From Zephyr® Endobronchial Valve Treatment

Zephyr® Endobronchial Valve EBV® treatment improved FEV1 in patients with heterogeneous emphysema.

E-Cigarette Use Associated With Increased Risk for COPD

Using e-cigarettes every day or some days increased the likelihood of developing chronic obstructive pulmonary disease.

Emphysema Threshold on CT Imaging May Have Predictive Value for COPD

Patients with chronic obstructive pulmonary disease with 5% emphysema based on thoracic computed tomography (CT) imaging may be at a greater risk for poor outcomes.

Lung Cancer Risk May Be Predicted by Frequency of COPD Exacerbations

Independent predictive factors of lung cancer in chronic obstructive pulmonary disease may include frequency of exacerbations, in addition to airflow obstruction and visual emphysema.

COPD, Respiratory Symptoms Associated With "Western" Diet

Researchers used data from the Atherosclerosis Risk in Communities Study to assess associations between dietary pattern and pulmonary assessments.

Respiratory Symptoms in Young Adults: Prognostic Value for Later Lung Function?

Respiratory symptoms that develop between the ages of 18 and 30 may hold prognostic value for later decline in lung function.

Progression of Emphysema With Regular Aspirin Use

Regular use of aspirin may slow the progression of emphysema.

Measuring Outcomes After Stent Placement: An Interview With Gaetane C. Michaud, MD

New Research in Airway Diseases: An Interview With Gaetane C. Michaud, MD

A Team Approach to Interventional Pulmonology: An Interview With Gaetane C. Michaud, MD

Long-Term Effects of Airway Stenting: An Interview With Gaetane C. Michaud, MD

Making the Case for Airway Stenting: An Interview With Gaetane C. Michaud, MD

Introduction to Airway Stents: An Interview With Gaetane C. Michaud, MD

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

A recent study examined whether nebulized glycopyrrolate is safe to use in patients with severe COPD and comorbid cardiovascular risk factors.

COPD: Concurrent Nebulized Glycopyrrolate, Long-Acting Bronchodilators Safe

The safety of concurrently administering nebulized glycopyrrolate with long-acting beta agonists was examined in 3 studies.

Improving Lung Function in Heterogenous Emphysema: Endobronchial Valves vs Standard of Care

Forced expiratory volume in 1 second and length of hospital stay were assess to determine the benefit of endobronchial valve placement vs standard of care in emphysema.

Expert Panel Updates Recommendations for Endoscopic Lung Volume Reduction for Emphysema

Advanced emphysema may benefit from endoscopic lung reduction treatment.

ACEi, ARB Use Improves Pulmonary Function in Emphysema

Higher doses were independently linked to slower change in emphysema, especially among former smokers

ACE Inhibitors, ARBs Slow Progression of Emphysema

Treatment with full-dose angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers was found to slow disease progression in patients with emphysema.